Free Trial
OTCMKTS:TRLPF

Acerus Pharmaceuticals (TRLPF) Stock Price, News & Analysis

Acerus Pharmaceuticals logo
$0.22 0.00 (0.00%)
As of 07/21/2023

About Acerus Pharmaceuticals Stock (OTCMKTS:TRLPF)

Key Stats

Today's Range
$0.22
$0.22
50-Day Range
$0.22
$0.22
52-Week Range
$0.08
$0.34
Volume
N/A
Average Volume
5,474 shs
Market Capitalization
$56.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRLPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acerus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRLPF Stock News Headlines

Takeda Pharmaceutical Co. Ltd. ADR
"I'm risking my reputation on this"
A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity.tc pixel
Acerus Reports Second Quarter 2022 Financial Results
See More Headlines

TRLPF Stock Analysis - Frequently Asked Questions

Acerus Pharmaceuticals' stock was trading at $0.22 at the start of the year. Since then, TRLPF stock has increased by 0.0% and is now trading at $0.22.

Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF) issued its quarterly earnings results on Monday, November, 5th. The specialty pharmaceutical company reported ($0.01) EPS for the quarter, meeting analysts' consensus estimates of ($0.01). The specialty pharmaceutical company earned $1.58 million during the quarter. Acerus Pharmaceuticals had a negative trailing twelve-month return on equity of 346.72% and a negative net margin of 254.66%.

Shares of TRLPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/05/2018
Today
9/01/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRLPF
CIK
N/A
Fax
N/A
Employees
29
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($0.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.79 million
Net Margins
-254.66%
Pretax Margin
N/A
Return on Equity
-346.72%
Return on Assets
-94.54%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.35
Quick Ratio
0.90

Sales & Book Value

Annual Sales
$7.38 million
Price / Sales
7.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
258,615,000
Free Float
N/A
Market Cap
$56.90 million
Optionable
Not Optionable
Beta
2.60

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:TRLPF) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners